CLINICAL IMPLICATIONS OF SLOW SULFOXIDATION OF THIORIDAZINE IN A POOR METABOLIZER OF THE DEBRISOQUINE TYPE

被引:65
作者
MEYER, JW
WOGGON, B
BAUMANN, P
MEYER, UA
机构
[1] UNIV ZURICH,HOSP PSYCHIAT,RES DEPT,CH-8006 ZURICH,SWITZERLAND
[2] UNIV LAUSANNE,HOSP PSYCHIAT,RES DEPT,PRILLY,SWITZERLAND
[3] UNIV BASEL,BIOCTR,CH-4056 BASEL,SWITZERLAND
关键词
D O I
10.1007/BF00316110
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:613 / 614
页数:2
相关论文
共 10 条
[1]   GC AND GC-MS PROCEDURES FOR SIMULTANEOUS PHENOTYPING WITH DEXTROMETHORPHAN AND MEPHENYTOIN [J].
BAUMANN, P ;
JONZIERPEREY, M .
CLINICA CHIMICA ACTA, 1988, 171 (2-3) :211-222
[2]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[3]  
Evans D A, 1986, Prog Clin Biol Res, V214, P491
[4]  
GONZALES FJ, 1988, NATURE, V33, P442
[5]   SIMULTANEOUS DETERMINATION OF THIORIDAZINE AND ITS OXIDIZED AND N-DEMETHYLATED METABOLITES USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON RADIALLY COMPRESSED SILICA [J].
KILTS, CD ;
PATRICK, KS ;
BREESE, GR ;
MAILMAN, RB .
JOURNAL OF CHROMATOGRAPHY, 1982, 231 (02) :377-391
[6]  
MAGHOUB A, 1977, LANCET, V2, P584
[7]   THE MOLECULAR MECHANISMS OF 2 COMMON POLYMORPHISMS OF DRUG OXIDATION - EVIDENCE FOR FUNCTIONAL-CHANGES IN CYTOCHROME-P-450 ISOZYMES CATALYZING BUFURALOL AND MEPHENYTOIN OXIDATION [J].
MEYER, UA ;
GUT, J ;
KRONBACH, T ;
SKODA, C ;
MEIER, UT ;
CATIN, T ;
DAYER, P .
XENOBIOTICA, 1986, 16 (05) :449-464
[8]   POLYMORPHIC DEXTROMETHORPHAN METABOLISM - CO-SEGREGATION OF OXIDATIVE O-DEMETHYLATION WITH DEBRISOQUIN HYDROXYLATION [J].
SCHMID, B ;
BIRCHER, J ;
PREISIG, R ;
KUPFER, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) :618-624
[9]   2 MUTANT ALLELES OF THE HUMAN CYTOCHROME-P-450DB1 GENE (P450C2D1) ASSOCIATED WITH GENETICALLY DEFICIENT METABOLISM OF DEBRISOQUINE AND OTHER DRUGS [J].
SKODA, RC ;
GONZALEZ, FJ ;
DEMIERRE, A ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5240-5243
[10]  
VONBAHR C, 1985, CLIN PHARM PSYCHIATR